about
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleo...
Read More
1.65
-0.13
(-7.30%)
1.1M
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for PepGen Inc is on 15 May 2026 for the purpose of PepGen Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
PepGen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..